17738

543950

YATHARTH

img img img img
No Data Available

YATHARTH HOSP & TRA C S L Share Price Update

As of the latest trading session, YATHARTH HOSP & TRA C S L is trading at ₹832.85, up by ₹24.34 or 3.01% from its previous close. The stock has moved between ₹809.00 and ₹845.00 today. Over the past year, the stock has delivered a return of 62.10%. In the last month, it has returned 8.70%.

YATHARTH HOSP & TRA C S L performance

Today’s low Today’s high
₹ 809.00 ₹ 845.00
₹ 832.85
52 week low 52 week high
₹ 485.00 ₹ 887.85
₹ 832.85
Open Price ₹ 809.10
Prev. Close ₹ 808.50
Volume (Shares) 340832.00
Total traded value ₹ 2838.61
Upper Circuit ₹ 970.20
Lower Circuit ₹ 646.80
info

Investment Returns

Over 1 Month 8.70% Over 3 Months 16.60% Over 6 Months 4.04% Over 1 Year 62.10%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

YATHARTH HOSP & TRA C S L fundamentals


  • Market cap (Cr) 8,024.90
  • P/E Ratio (TTM) 83.29
  • Beta 0.98
  • Book Value / share 163.24
  • Return on equity 7.42%
  • EPS (TTM) 9.71
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 23.89
info icon alternate text
  • Market cap (Cr) 8,012.80
  • P/E Ratio (TTM) 83.29
  • Beta 0.85
  • Book Value / share 163.24
  • Return on equity 7.42%
  • EPS (TTM) 9.71
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 23.89
info icon alternate text

YATHARTH HOSP & TRA C S L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 158.15
Operating Expense 131.51
Net Profit 23.89
Net Profit Margin (%) 15.10
Earnings Per Share (EPS) 2.48
EBITDA 42.01
Effective Tax Rate (%) 25.56
Particulars SEP 2025 (Values in Cr)
Revenue 137.29
Operating Expense 116.85
Net Profit 20.64
Net Profit Margin (%) 15.03
Earnings Per Share (EPS) 2.14
EBITDA 33.11
Effective Tax Rate (%) 22.40
Particulars JUN 2025 (Values in Cr)
Revenue 130.14
Operating Expense 99.94
Net Profit 27.12
Net Profit Margin (%) 20.83
Earnings Per Share (EPS) 2.81
EBITDA 42.31
Effective Tax Rate (%) 27.62
Particulars MAR 2025 (Values in Cr)
Revenue 111.99
Operating Expense 85.08
Net Profit 21.90
Net Profit Margin (%) 19.55
Earnings Per Share (EPS) 2.55
EBITDA 35.87
Effective Tax Rate (%) 29.40
Particulars DEC 2024 (Values in Cr)
Revenue 110.41
Operating Expense 83.95
Net Profit 22.25
Net Profit Margin (%) 20.15
Earnings Per Share (EPS) 2.60
EBITDA 34.96
Effective Tax Rate (%) 24.88
Particulars MAR 2025 (Values in Cr)
Revenue 454.24
Operating Expense 346.51
Net Profit 87.69
Net Profit Margin (%) 19.30
Earnings Per Share (EPS) 9.89
EBITDA 138.71
Effective Tax Rate (%) 26.57
Particulars MAR 2024 (Values in Cr)
Revenue 419.79
Operating Expense 320.24
Net Profit 83.99
Net Profit Margin (%) 20.00
Earnings Per Share (EPS) 10.61
EBITDA 130.88
Effective Tax Rate (%) 25.74
Particulars MAR 2023 (Values in Cr)
Revenue 371.51
Operating Expense 287.59
Net Profit 64.17
Net Profit Margin (%) 17.27
Earnings Per Share (EPS) 9.83
EBITDA 106.91
Effective Tax Rate (%) 24.96
Particulars MAR 2022 (Values in Cr)
Revenue 298.59
Operating Expense 239.54
Net Profit 42.09
Net Profit Margin (%) 14.09
Earnings Per Share (EPS) 6.46
EBITDA 85.45
Effective Tax Rate (%) 30.22
Particulars MAR 2021 (Values in Cr)
Revenue 164.73
Operating Expense 147.47
Net Profit 12.34
Net Profit Margin (%) 7.49
Earnings Per Share (EPS) 7.54
EBITDA 44.31
Effective Tax Rate (%) 30.51
Particulars MAR 2025 (Values in Cr)
Book Value / Share 166.62
ROE % 10.53
ROCE % 14.27
Total Debt to Total Equity 0.04
EBITDA Margin 27.42
Particulars MAR 2024 (Values in Cr)
Book Value / Share 101.84
ROE % 21.66
ROCE % 23.82
Total Debt to Total Equity 0.33
EBITDA Margin 29.47
Particulars MAR 2023 (Values in Cr)
Book Value / Share 27.93
ROE % 43.87
ROCE % 26.51
Total Debt to Total Equity 1.77
EBITDA Margin 26.52
Particulars MAR 2022 (Values in Cr)
Book Value / Share 17.84
ROE % 46.64
ROCE % 26.48
Total Debt to Total Equity 2.41
EBITDA Margin 28.34
Particulars MAR 2021 (Values in Cr)
Book Value / Share 44.24
ROE % 30.91
ROCE % 18.69
Total Debt to Total Equity 3.05
EBITDA Margin 29.99
Particulars MAR 2025 (Values in Cr)
Book Value / Share 158.29
ROE % 7.42
ROCE % 10.36
Total Debt to Total Equity 0.01
EBITDA Margin 31.25
Particulars MAR 2024 (Values in Cr)
Book Value / Share 97.49
ROE % 16.58
ROCE % 20.91
Total Debt to Total Equity 0.12
EBITDA Margin 31.55
Particulars MAR 2023 (Values in Cr)
Book Value / Share 26.88
ROE % 44.59
ROCE % 36.14
Total Debt to Total Equity 0.81
EBITDA Margin 29.05
Particulars MAR 2022 (Values in Cr)
Book Value / Share 17.05
ROE % 46.49
ROCE % 35.13
Total Debt to Total Equity 1.20
EBITDA Margin 28.90
Particulars MAR 2021 (Values in Cr)
Book Value / Share 42.34
ROE % 19.63
ROCE % 17.16
Total Debt to Total Equity 1.72
EBITDA Margin 27.34
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 440.57
Total Assets 1731.17
Total Liabilities 1731.17
Total Equity 1637.13
Share Outstanding 9
Price to Book Ratio 2.68
Return on Assets (%) 7.54
Return on Capital (%) 7.95
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 238.63
Total Assets 1019.33
Total Liabilities 1019.33
Total Equity 874.32
Share Outstanding 8
Price to Book Ratio 4.28
Return on Assets (%) 11.23
Return on Capital (%) 11.96
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 38.44
Total Assets 485.96
Total Liabilities 485.96
Total Equity 182.96
Share Outstanding 6
Price to Book Ratio 0.00
Return on Assets (%) 13.53
Return on Capital (%) 14.72
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 12.08
Total Assets 426.02
Total Liabilities 426.02
Total Equity 116.88
Share Outstanding 6
Price to Book Ratio 0.00
Return on Assets (%) 10.36
Return on Capital (%) 11.77
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 5.15
Total Assets 308.77
Total Liabilities 308.77
Total Equity 80.68
Share Outstanding 1
Price to Book Ratio 0.00
Return on Assets (%) 5.88
Return on Capital (%) 6.81
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 299.49
Total Assets 1574.65
Total Liabilities 1574.65
Total Equity 1525.14
Share Outstanding 9
Price to Book Ratio 2.68
Return on Assets (%) 5.56
Return on Capital (%) 5.75
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 227.00
Total Assets 878.38
Total Liabilities 878.38
Total Equity 836.98
Share Outstanding 8
Price to Book Ratio 4.28
Return on Assets (%) 9.56
Return on Capital (%) 9.99
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 12.73
Total Assets 326.23
Total Liabilities 326.23
Total Equity 176.12
Share Outstanding 6
Price to Book Ratio 0.00
Return on Assets (%) 19.67
Return on Capital (%) 22.15
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.83
Total Assets 285.87
Total Liabilities 285.87
Total Equity 111.71
Share Outstanding 6
Price to Book Ratio 0.00
Return on Assets (%) 14.72
Return on Capital (%) 19.05
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.77
Total Assets 211.47
Total Liabilities 211.47
Total Equity 69.35
Share Outstanding 1
Price to Book Ratio 0.00
Return on Assets (%) 5.83
Return on Capital (%) 7.16
Particulars MAR 2025 (Values in Cr)
Net Income 171.73
Cash from Operations 176.19
Cash from Investing -420.16
Cash from Financing 519.49
Net change in Cash 248.94
Free Cash Flow 487.02
Particulars MAR 2024 (Values in Cr)
Net Income 156.83
Cash from Operations 40.67
Cash from Investing -225.86
Cash from Financing 304.20
Net change in Cash 75.26
Free Cash Flow 134.03
Particulars MAR 2023 (Values in Cr)
Net Income 87.67
Cash from Operations 101.18
Cash from Investing -20.31
Cash from Financing -17.74
Net change in Cash 25.72
Free Cash Flow 120.99
Particulars MAR 2022 (Values in Cr)
Net Income 63.10
Cash from Operations 72.95
Cash from Investing -52.17
Cash from Financing -1.12
Net change in Cash 6.63
Free Cash Flow 112.32
Particulars MAR 2021 (Values in Cr)
Net Income 28.12
Cash from Operations 45.92
Cash from Investing -21.23
Cash from Financing -19.05
Net change in Cash 3.38
Free Cash Flow 66.05
Particulars MAR 2025 (Values in Cr)
Net Income 119.43
Cash from Operations 101.74
Cash from Investing -297.75
Cash from Financing 346.62
Net change in Cash 137.54
Free Cash Flow 306.68
Particulars MAR 2024 (Values in Cr)
Net Income 113.11
Cash from Operations 51.76
Cash from Investing -167.47
Cash from Financing 240.58
Net change in Cash 89.07
Free Cash Flow 85.77
Particulars MAR 2023 (Values in Cr)
Net Income 85.52
Cash from Operations 57.78
Cash from Investing -8.66
Cash from Financing -6.25
Net change in Cash 10.66
Free Cash Flow 66.25
Particulars MAR 2022 (Values in Cr)
Net Income 60.31
Cash from Operations 36.14
Cash from Investing -18.46
Cash from Financing -7.47
Net change in Cash 0.86
Free Cash Flow 41.78
Particulars MAR 2021 (Values in Cr)
Net Income 17.76
Cash from Operations 26.15
Cash from Investing -3.68
Cash from Financing -22.73
Net change in Cash -0.65
Free Cash Flow 28.72
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8021.10 63.49 12.69 115331.11 6680.00 8249.95
FORTIS MALAR HOSPITALS LIMITED 52.81 23.90 2.88 98.98 40.75 78.80
SHREE PACETRONIX LTD. 127.40 19.22 2.81 47.77 66.10 283.15
TRANSGENE BIOTEK LTD. 3.14 0.00 2.58 23.79 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8021.10 79.41 12.38 115331.11 6680.00 8249.95
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 38.48 0.00 -11.18 28.74 30.30 57.48
KOVAI MEDICAL CENTER & HO 5360.90 24.87 4.92 5864.82 5010.00 6725.00

YATHARTH HOSP & TRA C S L shareholding pattern

Holding
26.94%
55.79%
5.25%
12.0%
10.73%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

YATHARTH HOSP & TRA C S L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
832.85 3.01 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 821.00
  • 26 Days 787.00
  • 10 Days 819.40
  • 50 Days 751.40
  • 12 Days 816.20
  • 100 Days 721.20
  • 20 Days 799.40
  • 200 Days 689.90
812.13 PIVOT
First Support 796.47 First Resistance 824.17 Second Support 784.43 Second Resistance 839.83 Third Support 768.77 Third Resistance 851.87
RSI 55.79 ADX 53.15 MACD 29.16 Williams % R -52.36 Commodity Channel Index (CCI) 25.12
Date 2026-05-18 Week 181502.00 Same Day 133757.00 Month 233687.00
1 Year 0.98 3 Year 0.98
Over 1 Month
8.70% down
Over 1 Year
62.10% down
Over 3 Months
16.60% down
Over 3 Years
34.28% down
Over 6 Months
4.04% down
Over 5 Years
0.00% down

YATHARTH HOSP & TRA C S L Corporate Actions

Top Gainers

Top Losers

YATHARTH HOSP & TRA C S L Share Price

Yatharth Hospital & Trauma Care Services Limited was formerly incorporated as a Private Limited Company in Delhi dated February 28, 2008. On November 3, 2021, the status converted into a Public Company and name of the Company was changed to Yatharth Hospital & Trauma Care Services Limited' on November 18, 2021 issued by the RoC.

Yatharth Hospitals and Trauma Care Services Limited is a network of super speciality hospitals across Delhi National Capital Region (NCR) and Madhya Pradesh, capitalising on the robust healthcare infrastructure in these regions to serve a wide patient base in need of tertiary care.
The Company operate three super specialty hospitals in Delhi NCR, i.e., at Greater Noida, Uttar Pradesh. The super speciality tertiary care
hospital currently operates with 400 beds, including 112 critical care beds and 9 modular operation theatres, among other surgical facilities. I. At present, the Company is engaged in provision of healthcare services.

The Company started operations in 2008 with a clinic in Noida, Uttar Pradesh and thereafter, established its first hospital in Greater Noida, Uttar Pradesh in November 2010. The second hospital in Noida, Uttar Pradesh commenced operations in 2013 as a 250-bedded super-specialty tertiary care hospital. The third hospital located in Noida Extension, Uttar Pradesh is a 450-bedded tertiary care hospital with a mix of 11 modular and other operation theatres. It also has 125 critical care beds, and had commenced operations in May 2019. In February 2022, the Company acquired a 305-bedded Ramraja Multi-Speciality Hospital in Orchha, Madhya Pradesh near Jhansi, Uttar Pradesh, which commenced commercial operations effective from April 10, 2022.

The Company made an Initial Public Offer by raising funds from public aggregating to Rs 686.56 Crore by issuing upto 22,885,023 Equity Shares, comprising a Fresh Issue of 16,333,333 Equity Shares aggregating to Rs 490 Crore and an Offer for Sale of 6,551,690 Equity Shares aggregating to Rs 196.56 Crore in July, 2023.

In 2024, Yatharth Hospitals, marked the launching of Radiation Oncology and Nuclear Medicine Center at the NOIDA Extension Facility. It acquired the fifth hospital, in Faridabad, Haryana, adding 200 beds in February, 2024 and made it operational in May 2024. Further, Company acquired two hospitals, first in Model Town, Delhi and second in Sector 20, Faridabad, Haryana in FY2025.

Parent organization Indian Private
NSE symbol YATHARTH
Founded 2008
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Yatharth Hospital & Trauma Care Services Ltd?

Answer Field

Yatharth Hospital & Trauma Care Services Ltd share price is for NSE ₹ 832.85 & for BSE ₹ 831.60 as on May 19 2026 03:30 PM.

What is the Market Cap of Yatharth Hospital & Trauma Care Services Ltd Share?

Answer Field

The market cap of Yatharth Hospital & Trauma Care Services Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on May 19 2026 03:30 PM.

What is the 52 Week High and Low of Yatharth Hospital & Trauma Care Services Ltd?

Answer Field

The 52 Week High and Low of Yatharth Hospital & Trauma Care Services Ltd for NSE is ₹ 887.85 and ₹ 485.00 and for BSE is ₹ 887.15 and ₹ 484.90.

What is 1 year return for Yatharth Hospital & Trauma Care Services Ltd?

Answer Field

The 1 year returns on the stock has been 62.10%.

What is the P/E Ratio of Yatharth Hospital & Trauma Care Services Ltd Share?

Answer Field

As on May 19 2026 03:30 PM the price-to-earnings (PE) ratio for Yatharth Hospital & Trauma Care Services Ltd share is 83.29.

What is the PB ratio of Yatharth Hospital & Trauma Care Services Ltd Share?

Answer Field

As on May 19 2026 03:30 PM, the price-to-book (PB) ratio for Yatharth Hospital & Trauma Care Services Ltd share is 163.24.

How to Buy Yatharth Hospital & Trauma Care Services Ltd Share?

Answer Field

You can trade in Yatharth Hospital & Trauma Care Services Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Yatharth Hospital & Trauma Care Services Ltd Share on Bajaj Broking App?

Answer Field

To buy Yatharth Hospital & Trauma Care Services Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Yatharth Hospital & Trauma Care Services Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|